International Union of Pharmacology. XXVIII. Proteinase-activated receptors.
Proteinase-activated receptors (PARs) represent a unique subclass of G-protein-coupled receptors of which four family members have now been cloned from a number of species. The novel mechanism of receptor activation involves the proteolytic unmasking of a cryptic N-terminal receptor sequence that, remaining tethered, binds to and triggers receptor function. In addition, short (five to six amino acids) synthetic peptides, based on the proteolytically revealed motif, can activate PARs without the unmasking of the tethered ligand. This article summarizes the experiments leading to the pharmacological characterization and cloning of the four PAR family members and provides a rationale for their designation by the acronym "PAR". The ability to distinguish among the PARs pharmacologically 1) with selective proteinase activators, 2) with receptor-selective peptide agonists, and 3) with peptide and nonpeptide antagonists is discussed, as are the molecular mechanisms of receptor activation and desensitization/internalization. Finally, the potential physiological roles of the PARs, which are widely distributed in many organs in the settings of tissue injury, repair, and remodeling, including embryogenesis and oncogenesis are discussed, and the newly appreciated roles of proteinases as signaling molecules that can act as either functional agonists or antagonists are highlighted.
Hollenberg
Morley D
MD
Department of Pharmacology and Therapeutics, University of Calgary, Faculty of Medicine, Calgary, Alberta, Canada. mhollenb@ucalgary.ca
Compton
Steven J
SJ
D006801:Humans; D007390:International Agencies; D009842:Oligopeptides / Q000378:metabolism*; D018179:Receptors, Thrombin / Q000145:classification* / Q000378:metabolism / Q000502:physiology*; D013329:Structure-Activity Relationship; D009626:Terminology as Topic
D009842:Oligopeptides; D018179:Receptors, Thrombin